Company: ELV
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001193125-25-197796
Chunk: 23

Company: Elevance Health, Inc.
Filing Date: 2025-09-08
Form: 424B3
Chunk 23
---
 not limit the aggregate amount of debt securities that may be issued under the indenture, nor does it limit the number of other series or the aggregate amount of any
particular series. The 2028 notes will be limited initially to $ aggregate principal amount, the 2032 notes will be limited initially to $ aggregate principal amount, the 2036 notes will be limited initially to
$ aggregate principal amount and the 2055 notes will be limited initially to $ aggregate principal amount. We may “re-open” any series of notes at any time without the
consent of the noteholders. We may issue additional securities from time to time after this offering. The notes of any series and any additional new notes at any time of such series subsequently issued under the indenture would be treated as a
single series for all purposes under the indenture, including, without limitation, waivers, amendments, redemptions and offers to purchase; provided that if such additional notes are not fungible with such notes for U.S. federal income tax purposes,
the additional notes will have a separate CUSIP number.

S-16

The indenture and the notes do not limit our ability to incur other debt or to issue other securities. When we refer to a series of debt securities, we mean a series, such as each of the series of notes we are offering by means of this prospectus supplement and the accompanying prospectus, issued under the indenture. When we refer to the notes or these notes, we mean each series of notes we are offering by means of this prospectus supplement and the accompanying prospectus. Defeasance The notes may be defeased, at our option, through legal defeasance or covenant defeasance as provided for in the indenture and as described in the accompanying prospectus under the captions “ Description of the Debt Securities—Defeasance” and “ Description of the Debt Securities—Satisfaction and Discharge.” Book-Entry Notes Each series of notes will be issued in the form of one or more global notes in definitive, fully registered form, without interest coupons (the “Global Note”). Each Global Note will be deposited with the trustee, as custodian for, and registered in the name of a nominee of, DTC as depository, and will be held through the book-entry system of DTC and its participants, including Euroclear and Clearstream. See “ Description of the Debt Securities—Global Notes, Delivery and Form” in the accompanying prospectus for a description of registered Global Notes